Health Outcomes Among Individuals Exposed to Medical Products

These assessments examine the occurrence of pre-specified health outcomes, or health events, among individuals exposed to particular medical products. Health outcomes can include the subsequent occurrence of new diagnoses, additional medical procedures, or use of other additional medical products (or combinations of these). The specifications of an assessment can vary widely based on the definition of exposures, comparators, outcomes, cohort inclusion and exclusion criteria, time periods, and analytic approaches. There are three subcategories of assessments:

  • Modular program based one-time assessments. These assessments provide rapid response by making use of adaptable standardized programs ("modular programs"). These assessments can provide stratified results by age group, sex, and calendar year.
  • Protocol based one-time assessments. These assessments use customized study designs and protocols that allow 1) detailed specification of exposure groups and health events, 2) adjustment for a range of potential confounding factors, and 3) comparison of event rates between different medical products. They may use a variety of study designs and statistical methods.
  • Protocol based repeated assessments. These assessments involve repeated evaluation of information as it accrues within the Mini-Sentinel Distributed Dataset. They use customized study designs and protocols that allow 1) detailed specification of exposure groups and health events, 2) adjustment for a range of potential confounding factors, and 3) comparison of event rates between different medical products. They may use a variety of study designs and statistical methods, including sequential methods.

Disclaimer

The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

 

Search by keywords:  

Results from Assessments of Health Outcomes Among Individuals Exposed to Medical Products Search
 TitleAssessment TypeStatusDate Posted
DetailsIntussusception Risk After Rotavirus Vaccination in U.S. InfantsProtocol-basedComplete 6-14-2013
DetailsOxicam NSAIDs, modafinil/armodafinil, sulfamothoxazole & Severe Cutaneous Adverse Reaction (SCAR) eventsModular programComplete 6-07-2013
DetailsAngiotensin Receptor Blockers (ARBs), hydrochlorothiazide, atenolol, amlodipine use & celiac diseaseModular programComplete 6-07-2013
DetailsDabigatran, warfarin & GI bleed, intracerebral hemorrhageModular programComplete 5-03-2013
DetailsWarfarin & GI bleed, intracerebral hemorrhageModular programComplete 5-03-2013
DetailsInfluenza vaccines and febrile seizures v2.0 (PRISM)Protocol basedIn progress 5-02-2013
DetailsAnti-diabetes drugs & acute myocardial infarctionProtocol-basedIn progress 4-23-2013
DetailsInfluenza vaccines and pregnancy outcomes (PRISM)Protocol-basedProtocol in preparation 2-27-2013
DetailsInfluenza vaccine safety sequential analysis (PRISM)Protocol-basedProtocol in preparation 2-27-2013
DetailsPrevnar 13 vaccine and Kawasaki disease (PRISM)Protocol-basedProtocol in preparation 2-27-2013
DetailsThromboembolic events after immunoglobulin administrationProtocol-basedProtocol in preparation 2-27-2013
DetailsProjected Timelines for CBER Protocol-Based Mini-Sentinel Medical Product AssessmentsProtocol-basedOngoing 2-27-2013
DetailsInfluenza vaccines and birth outcomes (PRISM)Protocol-basedIn progress 2-25-2013
DetailsDabigatran (Pradaxa), warfarin & GI bleed, intracerebral hemorrhageModular Program based one-timeComplete 2-15-2013
DetailsNatalizumab, efalizumab, & progressive multifocal leukoencephalopathy (PML)Modular Program based one-timeComplete 1-11-2013
DetailsDrugs that act on the renin-angiotensin-aldosterone system (angiotensin converting enzyme inhibitors, angiotensin receptor blockers, aliskiren) & angioedemaProtocol based one-timeComplete 10-23-2012
DetailsRoutine prospective safety surveillance for new drugs, vaccines, and other biologic productsVarious assessment typesIn progress 7-10-2012
DetailsGardasil vaccination and venous thromboembolism (PRISM)Protocol based one-time assessmentIn progress 3-30-2012
DetailsSmoking cessation drugs & cardiovascular outcomesModular program based one-timeComplete 1-17-2012
DetailsAngiotensin II receptor blockers & celiac diseaseModular program based one-timeComplete 1-17-2012